Skip to main content

Displaying 7585 - 7608 of 17309

[PLUS] Dynamic Portfolio Management

November 2, 2022

From the desk of Willie Delwiche.

With fear subsiding but strength slow to emerge, downside tactical risks are rising. We reduced the equity exposure in our Tactical Opportunity portfolio and have moved more cash to the sideline.

[PLUS] Weekly Sentiment Report

November 2, 2022

From the desk of Willie Delwiche.

Households Stick With Stocks

Household equity exposure is ten percentage points below its November 2021 peak. Even with that decline, it is only now approaching its long-term average. Bond exposure remains below its long-term average and cash exposure in October moved above its long-term average for the first time since COVID. 

Why It Matters: Moods are sour, but for all the talk of rampant pessimism & historic levels of bearishness, individual investors have not abandoned stocks. This is as evident in the AAII asset allocation survey as it is in the latest ETF flow data. For the amount of pessimism that is being seen elsewhere, there is relatively little cash on the sidelines. If there is an underowned and unloved asset class it is either bonds or commodities, not stocks.  

In this week’s Sentiment Report we take a closer look at how investors are feeling and how that squares with what they are doing.

 

All Star Charts Crypto

What's Up, Doge?

November 2, 2022

Dogecoin and other meme coins are seeing a boom off the back of Elon Musk's takeover of Twitter.

It isn't isolated to the Doge. A slew of meme coins have been born since Elon tweeted an image of a Shiba Inu dog wearing a Twitter t-shirt for Halloween.

It's hilarious that his tweets never fail to pump these things.

So, is a new meme coin season upon us?

 

 

The All Star Momentum Scan

November 2, 2022

We debuted a new scan recently which goes by the name- All Star Momentum.

All Star Momentum is a brand new scan that guides us toward the very best stocks in the market. We have incorporated our stock universe of Nifty 500 as the base this time around. Among the 500 stocks that we follow, this scan will pump out names that are most likely to outperform the market.

Performance

November 2, 2022

How do I measure performance?

In a nutshell, this is a question I received from a member of the All Star Charts community today.

Well, it depends

The short and obvious answer: I trade to make money

If I’m making money, good. If I’m not, bad.

Of course, there are also more nuanced answers and considerations – some more relevant than others. They come down to relative performance.

[PLUS] November Weight of the Evidence Dashboard: Bulls Need Breadth Thrust To Overcome Macro Malaise

November 1, 2022

From the desk of Willie Delwiche.

The Scales are more balanced than last month but are still tipped toward risk and away from opportunity. 

Macro folks are sorting out just how bearish they need to get while market folks are trying to figure out just how bullish they should get. From my perspective, less macro-related volatility could help stocks build on their October gains heading into year end. But there isn’t much evidence of that taking place just yet. With that, the inability of the recent rally to show sustainable strength (and more new highs than new lows) suggests caution remains warranted. 

Our Weight of the Evidence Dashboard fills in the details and includes a few charts that have our attention heading into November.

 

All Star Charts Crypto

We're Watching These Cryptos

November 1, 2022

As technicians, we pride ourselves on never being dogmatic in our approach. If new data that invalidates our initial thesis presents itself, we're always willing to flip our approach.

Yesterday, we wrote that Ethereum testing a significant support zone suggests this rally is mean-reverting in nature. In that same breath, though, we noted that it's wise to treat every chart on its own merits.

If you adopt an overly broad picture of markets, you'll often miss some of the most straightforward trading opportunities.

With all that said, a few names are shaping up nicely in this tape.

 

 

 

Five CEOs Report Insider Buys

November 1, 2022

Our list is full of insider buys by company CEOs today.

The largest insider transaction is a Form 4 filing by the CEO of Biohaven Pharmaceutical Holding Company $BHVN, Vlad Coric.